Additionally, GLP-1 RA use was protective against wet AMD but only when comparing patients taking insulin (HR = .62) and statins (HR = .69)
[11] In a randomized controlled trial (RCT) comparing liraglutide, glargine, glimepiride, and sitagliptin (all added to metformin) with a follow-up of five years, glargine and liraglutide were modestly more effective in achieving and maintaining target HbA1c, [20] with no difference in outcomes of microvascular and cardiovascular disease
this peptide was named GLP-1
van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S
If left untreated, you may witness perennially high levels of blood sugar
Boxed Warning Its worth noting that Tirzepatide comes with a boxed warning regarding the risk of thyroid C-cell tumors